Not Medicare Enrolled

Dr. Alex De Jesus, MD

Rheumatology · San Antonio, TX
7959 FREDERICKSBURG RD, San Antonio, TX 78229
2103967410
Registered in NPPES since 2006
NPI: 1013986629 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. De Jesus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De Jesus? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. De Jesus

Dr. Alex De Jesus is a rheumatology specialist in San Antonio, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. De Jesus received a total of $180,051 from 32 pharmaceutical and/or device companies across 497 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. De Jesus is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $180,051 industry payments

Industry Payment Transparency

Open Payments through 2021 ↗
$180,051
Total received (2018-2021)
Avg $45,013/year across 4 years
Top 5% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
497
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2021
$2,396
2020
$19,334
2019
$46,393
2018
$111,929

Payments by company (2021)

Janssen Scientific Affairs, LLC
$1,000
Horizon Therapeutics plc
$337
Mallinckrodt Hospital Products Inc.
$186
UCB, Inc.
$141
E.R. Squibb & Sons, L.L.C.
$120
Pacira Therapeutics, Inc.
$91
Novartis Pharmaceuticals Corporation
$90
GlaxoSmithKline, LLC.
$69
Lilly USA, LLC
$63
Amgen Inc.
$61
Janssen Biotech, Inc.
$57
AstraZeneca Pharmaceuticals LP
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Antares Pharma, Inc.
$30
AbbVie Inc.
$26
PFIZER INC.
$19
GENZYME CORPORATION
$18
Organon LLC
$15
Top 3 companies account for 63.5% of 2021 payments
All-time payments by company (2018-2021) ›
Janssen Scientific Affairs, LLC
$137,085
AbbVie, Inc.
$23,443
Janssen Biotech, Inc.
$10,398
AbbVie Inc.
$4,056
Horizon Therapeutics plc
$1,011
E.R. Squibb & Sons, L.L.C.
$719
Novartis Pharmaceuticals Corporation
$387
UCB, Inc.
$317
Mallinckrodt Hospital Products Inc.
$311
Amgen Inc.
$290
GENZYME CORPORATION
$260
Genentech USA, Inc.
$220
PFIZER INC.
$185
GlaxoSmithKline, LLC.
$180
Antares Pharma, Inc.
$178
Radius Health, Inc.
$144
Lilly USA, LLC
$138
Mallinckrodt LLC
$137
Horizon Pharma plc
$136
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
Pacira Therapeutics, Inc.
$91
Mallinckrodt Enterprises LLC
$51
AstraZeneca Pharmaceuticals LP
$39
MEDEXUS PHARMA, INC.
$33
MEDAC PHARMA, INC.
$31
SANOFI-AVENTIS U.S. LLC
$25
FIDIA PHARMA USA INC.
$18
Flexion Therapeutics, Inc.
$17
Organon LLC
$15
Takeda Pharmaceuticals U.S.A., Inc.
$15
Bioventus LLC
$14
Ferring Pharmaceuticals Inc.
$12
Top 3 companies account for 94.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · COSENTYX · CUVITRU · Cimzia · Durolane · EUFLEXXA · EVENITY · Enbrel · HUMIRA · Humira · Hymovis · INFLECTRA · KEVZARA · KRYSTEXXA · OFEV · ORENCIA · OTREXUP · Otrexup · RAYOS · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · STELARA · SYNVISC-ONE · TALTZ · TREMFYA · Tymlos · XELJANZ · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in San Antonio?
Compare rheumatologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
50
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2021
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. De Jesus is a rheumatology specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. De Jesus receive payments from pharmaceutical companies?
Yes. Dr. De Jesus received a total of $180,051 from 32 companies across 497 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. De Jesus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →